4//SEC Filing
Gray Peter 4
Accession 0001232524-18-000150
CIK 0001232524other
Filed
Aug 12, 8:00 PM ET
Accepted
Aug 13, 6:47 PM ET
Size
13.0 KB
Accession
0001232524-18-000150
Insider Transaction Report
Form 4
Gray Peter
Director
Transactions
- Award
Ordinary Shares
2018-08-09+1,495→ 8,897 total - Sale
Ordinary Shares
2018-08-10$176.61/sh−715$126,277→ 8,182 total - Award
Non-Qualified Stock Option (right to buy)
2018-08-09+3,735→ 3,735 totalExercise: $177.73Exp: 2028-08-08→ Ordinary Shares (3,735 underlying)
Footnotes (4)
- [F1]These restricted stock units are granted pursuant to the Issuer's 2007 Non-Employee Directors Stock Award Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. Subject to the Reporting Person's continuous service and certain additional conditions, these units will vest in full on August 2, 2019.
- [F2]Shares sold to satisfy tax obligations arising out of the vesting of previously granted restricted stock units.
- [F3]Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $176.61 to $177.0615. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
- [F4]These options are granted pursuant to the Issuer's 2007 Non-Employee Directors Stock Award Plan. Subject to the Reporting Person's continuous service and certain additional conditions, these options will vest in 12 equal monthly installments beginning on September 1, 2018.
Issuer
Jazz Pharmaceuticals plc
CIK 0001232524
Entity typeother
Related Parties
1- filerCIK 0001576096
Filing Metadata
- Form type
- 4
- Filed
- Aug 12, 8:00 PM ET
- Accepted
- Aug 13, 6:47 PM ET
- Size
- 13.0 KB